surmount-1 tirzepatide weight loss percent nejm 2022 Surmount Press Briefing #ADA2022 Tirzepatide vs. Semaglutide for Patients

Hypotension In a pool of Study 1 and 2, hypotension occurred more frequently among patients taking ZEPBOUND (1.6%) than patients taking placebo (0.1%)

We saw with the first wave of GLP-1 drugs that some people had unpredictable reactions to Ozempic or Mounjaro, with life-altering side effects like stomach paralysis and sudden blindness

Because of this potential interaction, doctors often recommend that women using oral birth control switch to a non-oral contraception method, such as an IUD, implant, or barrier methods like condoms, while taking Tirzepatide

Mais les muscles en sont les victimes collatrales

Table of Contents: Who is a good candidate for tirzepatide therapy for weight loss and what criteria determine eligibility

Who Should Avoid Compounded Tirzepatide and Why